Assay results from Quebec caught the attention of a few gold explorer speculators Wednesday. Here’s some small stocks making big moves on Wednesday, June 20, 2018 (as of 4 pm EST):
Enforcer Gold Corp. (TSXV:VEIN) shares jumped 9% to $0.06 on Wednesday after the gold explorer announced results from its 2018 Phase 1 diamond drilling program on the MOP II gold-copper deposit in Quebec, which included 0.73 g/t gold over 219.7 metres.
As well, shares of iCo Therapeutics (TSXV:ICO) powered 106% higher to $0.165 as the biopharma company said it has completed the recruitment of all 32 subjects in the Company’s Phase 1 Oral Amphotericin B study, an approved drug for the treatment of fungal and parasitic conditions. The Company added that it currently expects results from the Phase 1 study in early July 2018.
Kraken Robotics Inc. (TSXV:PNG), meanwhile, reported that it has entered into a non-brokered private placement offering with Ocean Infinity Ltd., whereby Ocean Infinity will acquire 11,520,000 units at $0.20 per unit which, upon completion, will result in Ocean Infinity owning 9.99% of Kraken’s issued common shares. Kraken Robotics stock popped 33% to $0.20 following the announcement.
Finally, Pacton Gold Inc. (TSXV:PAC) shares rose 12% to $0.75 after the gold junior announced that it has entered into a binding letter of intent to acquire 100% of the Bellary Dome exploration license 47/2555 in the Pilbara region of Western Australia, located on the southern margin of the Hamersley Basin and surrounded by Novo Resources.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.